SPAGO — Spago Nanomedical AB (publ) Balance Sheet
0.000.00%
- SEK66.16m
- SEK54.90m
- SEK1.91m
Annual balance sheet for Spago Nanomedical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 28.4 | 52.5 | 62.1 | 45.2 | 32.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.707 | 0.894 | 0.711 | 1.36 | 3.87 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 29.8 | 54.4 | 65.2 | 51.9 | 38.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.08 | 1.07 | 0.853 | 0.925 | 0.613 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 163 | 192 | 206 | 53 | 39.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.15 | 6.81 | 8.8 | 11.5 | 5.86 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.15 | 6.81 | 8.8 | 11.7 | 6.35 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 160 | 185 | 197 | 41.3 | 33.2 |
| Total Liabilities & Shareholders' Equity | 163 | 192 | 206 | 53 | 39.6 |
| Total Common Shares Outstanding |